Episurf Medical AB (publ) (STO:EPIS.B)

Market Cap	70.14M
Revenue (ttm)	23.00M
Net Income (ttm)	-72.10M
Shares Out	653.06M
EPS (ttm)	-0.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	281,141
Average Volume	1,794,045
Open	0.1158
Previous Close	0.1158
Day's Range	0.1134 - 0.1158
52-Week Range	0.0963 - 0.4940
Beta	1.17
RSI	40.56
Earnings Date	Apr 10, 2025

About Episurf Medical AB

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The c...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 27
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: EPIS.B

Financial Performance

In 2024, Episurf Medical AB's revenue was 20.60 million, an increase of 4.04% compared to the previous year's 19.80 million. Losses were -76.00 million, -19.83% less than in 2023.